nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—Arrhythmia—Cisplatin—testicular cancer	0.00188	0.00188	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Sodium stibogluconate—Palpitations—Ifosfamide—testicular cancer	0.00188	0.00188	CcSEcCtD
Sodium stibogluconate—Sepsis—Epirubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Sodium stibogluconate—Pruritus—Chlorambucil—testicular cancer	0.00186	0.00186	CcSEcCtD
Sodium stibogluconate—Convulsion—Ifosfamide—testicular cancer	0.00184	0.00184	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Bleomycin—testicular cancer	0.00182	0.00182	CcSEcCtD
Sodium stibogluconate—Phlebitis—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Bleomycin—testicular cancer	0.00181	0.00181	CcSEcCtD
Sodium stibogluconate—Chest pain—Ifosfamide—testicular cancer	0.00181	0.00181	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Sodium stibogluconate—Flatulence—Cisplatin—testicular cancer	0.00181	0.00181	CcSEcCtD
Sodium stibogluconate—Anorexia—Dactinomycin—testicular cancer	0.0018	0.0018	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Chlorambucil—testicular cancer	0.00179	0.00179	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Vinblastine—testicular cancer	0.00177	0.00177	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Bleomycin—testicular cancer	0.00176	0.00176	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Ifosfamide—testicular cancer	0.00173	0.00173	CcSEcCtD
Sodium stibogluconate—Oedema—Ifosfamide—testicular cancer	0.00173	0.00173	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Sodium stibogluconate—Vision blurred—Cisplatin—testicular cancer	0.00173	0.00173	CcSEcCtD
Sodium stibogluconate—Asthenia—Vinblastine—testicular cancer	0.00172	0.00172	CcSEcCtD
Sodium stibogluconate—Infection—Ifosfamide—testicular cancer	0.00172	0.00172	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Methotrexate—testicular cancer	0.0017	0.0017	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Ifosfamide—testicular cancer	0.00168	0.00168	CcSEcCtD
Sodium stibogluconate—Vomiting—Chlorambucil—testicular cancer	0.00167	0.00167	CcSEcCtD
Sodium stibogluconate—Anorexia—Ifosfamide—testicular cancer	0.00165	0.00165	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Dactinomycin—testicular cancer	0.00165	0.00165	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vinblastine—testicular cancer	0.00164	0.00164	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Etoposide—testicular cancer	0.00164	0.00164	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Sodium stibogluconate—Fatigue—Dactinomycin—testicular cancer	0.00163	0.00163	CcSEcCtD
Sodium stibogluconate—Hypotension—Ifosfamide—testicular cancer	0.00162	0.00162	CcSEcCtD
Sodium stibogluconate—Urticaria—Bleomycin—testicular cancer	0.00161	0.00161	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Bleomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Sodium stibogluconate—Irritability—Methotrexate—testicular cancer	0.00159	0.00159	CcSEcCtD
Sodium stibogluconate—Dizziness—Vinblastine—testicular cancer	0.00159	0.00159	CcSEcCtD
Sodium stibogluconate—Convulsion—Cisplatin—testicular cancer	0.00159	0.00159	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Sodium stibogluconate—Nausea—Chlorambucil—testicular cancer	0.00156	0.00156	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Ifosfamide—testicular cancer	0.00156	0.00156	CcSEcCtD
Sodium stibogluconate—Anxiety—Cisplatin—testicular cancer	0.00155	0.00155	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00155	0.00155	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Ifosfamide—testicular cancer	0.00155	0.00155	CcSEcCtD
Sodium stibogluconate—Vomiting—Vinblastine—testicular cancer	0.00153	0.00153	CcSEcCtD
Sodium stibogluconate—Renal impairment—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Ifosfamide—testicular cancer	0.00151	0.00151	CcSEcCtD
Sodium stibogluconate—Headache—Vinblastine—testicular cancer	0.00151	0.00151	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Dactinomycin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Dactinomycin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium stibogluconate—Fatigue—Ifosfamide—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium stibogluconate—Oedema—Cisplatin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Cisplatin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Bleomycin—testicular cancer	0.0015	0.0015	CcSEcCtD
Sodium stibogluconate—Infection—Cisplatin—testicular cancer	0.00149	0.00149	CcSEcCtD
Sodium stibogluconate—Constipation—Ifosfamide—testicular cancer	0.00148	0.00148	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Etoposide—testicular cancer	0.00148	0.00148	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Sodium stibogluconate—Tachycardia—Cisplatin—testicular cancer	0.00146	0.00146	CcSEcCtD
Sodium stibogluconate—Asthenia—Bleomycin—testicular cancer	0.00146	0.00146	CcSEcCtD
Sodium stibogluconate—Convulsion—Etoposide—testicular cancer	0.00145	0.00145	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Cisplatin—testicular cancer	0.00145	0.00145	CcSEcCtD
Sodium stibogluconate—Pruritus—Bleomycin—testicular cancer	0.00144	0.00144	CcSEcCtD
Sodium stibogluconate—Chest pain—Etoposide—testicular cancer	0.00143	0.00143	CcSEcCtD
Sodium stibogluconate—Nausea—Vinblastine—testicular cancer	0.00143	0.00143	CcSEcCtD
Sodium stibogluconate—Anorexia—Cisplatin—testicular cancer	0.00143	0.00143	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00142	0.00142	CcSEcCtD
Sodium stibogluconate—Hypotension—Cisplatin—testicular cancer	0.0014	0.0014	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Dactinomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Sodium stibogluconate—Urticaria—Ifosfamide—testicular cancer	0.00138	0.00138	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Ifosfamide—testicular cancer	0.00137	0.00137	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Ifosfamide—testicular cancer	0.00137	0.00137	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Etoposide—testicular cancer	0.00137	0.00137	CcSEcCtD
Sodium stibogluconate—Infection—Etoposide—testicular cancer	0.00136	0.00136	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Sodium stibogluconate—Asthenia—Dactinomycin—testicular cancer	0.00136	0.00136	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Cisplatin—testicular cancer	0.00134	0.00134	CcSEcCtD
Sodium stibogluconate—Tachycardia—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Cisplatin—testicular cancer	0.00133	0.00133	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Sodium stibogluconate—Anorexia—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Cisplatin—testicular cancer	0.0013	0.0013	CcSEcCtD
Sodium stibogluconate—Bronchitis—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Dactinomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Sodium stibogluconate—Vomiting—Bleomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Sodium stibogluconate—Hypotension—Etoposide—testicular cancer	0.00128	0.00128	CcSEcCtD
Sodium stibogluconate—Rash—Bleomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Sodium stibogluconate—Dermatitis—Bleomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Ifosfamide—testicular cancer	0.00128	0.00128	CcSEcCtD
Sodium stibogluconate—Renal failure—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Sodium stibogluconate—Asthenia—Ifosfamide—testicular cancer	0.00124	0.00124	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Etoposide—testicular cancer	0.00123	0.00123	CcSEcCtD
Sodium stibogluconate—Pruritus—Ifosfamide—testicular cancer	0.00123	0.00123	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Sodium stibogluconate—Nausea—Bleomycin—testicular cancer	0.00121	0.00121	CcSEcCtD
Sodium stibogluconate—Vomiting—Dactinomycin—testicular cancer	0.0012	0.0012	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Sodium stibogluconate—Rash—Dactinomycin—testicular cancer	0.00119	0.00119	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Ifosfamide—testicular cancer	0.00119	0.00119	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Cisplatin—testicular cancer	0.00118	0.00118	CcSEcCtD
Sodium stibogluconate—Fatigue—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Sodium stibogluconate—Constipation—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Sodium stibogluconate—Dizziness—Ifosfamide—testicular cancer	0.00115	0.00115	CcSEcCtD
Sodium stibogluconate—Nausea—Dactinomycin—testicular cancer	0.00112	0.00112	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Sodium stibogluconate—Vomiting—Ifosfamide—testicular cancer	0.0011	0.0011	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Cisplatin—testicular cancer	0.0011	0.0011	CcSEcCtD
Sodium stibogluconate—Renal failure—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Sodium stibogluconate—Rash—Ifosfamide—testicular cancer	0.00109	0.00109	CcSEcCtD
Sodium stibogluconate—Dermatitis—Ifosfamide—testicular cancer	0.00109	0.00109	CcSEcCtD
Sodium stibogluconate—Urticaria—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Sodium stibogluconate—Asthenia—Cisplatin—testicular cancer	0.00107	0.00107	CcSEcCtD
Sodium stibogluconate—Nausea—Ifosfamide—testicular cancer	0.00103	0.00103	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Etoposide—testicular cancer	0.00101	0.00101	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—testicular cancer	0.000995	0.000995	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Methotrexate—testicular cancer	0.000984	0.000984	CcSEcCtD
Sodium stibogluconate—Asthenia—Etoposide—testicular cancer	0.000983	0.000983	CcSEcCtD
Sodium stibogluconate—Pruritus—Etoposide—testicular cancer	0.000969	0.000969	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—testicular cancer	0.000965	0.000965	CcSEcCtD
Sodium stibogluconate—Vomiting—Cisplatin—testicular cancer	0.000951	0.000951	CcSEcCtD
Sodium stibogluconate—Vision blurred—Methotrexate—testicular cancer	0.000947	0.000947	CcSEcCtD
Sodium stibogluconate—Rash—Cisplatin—testicular cancer	0.000943	0.000943	CcSEcCtD
Sodium stibogluconate—Dermatitis—Cisplatin—testicular cancer	0.000942	0.000942	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Etoposide—testicular cancer	0.000937	0.000937	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—testicular cancer	0.000927	0.000927	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Sodium stibogluconate—Dizziness—Etoposide—testicular cancer	0.000906	0.000906	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—testicular cancer	0.000893	0.000893	CcSEcCtD
Sodium stibogluconate—Nausea—Cisplatin—testicular cancer	0.000888	0.000888	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—testicular cancer	0.000887	0.000887	CcSEcCtD
Sodium stibogluconate—Convulsion—Methotrexate—testicular cancer	0.000871	0.000871	CcSEcCtD
Sodium stibogluconate—Vomiting—Etoposide—testicular cancer	0.000871	0.000871	CcSEcCtD
Sodium stibogluconate—Rash—Etoposide—testicular cancer	0.000864	0.000864	CcSEcCtD
Sodium stibogluconate—Dermatitis—Etoposide—testicular cancer	0.000863	0.000863	CcSEcCtD
Sodium stibogluconate—Headache—Etoposide—testicular cancer	0.000858	0.000858	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—testicular cancer	0.000858	0.000858	CcSEcCtD
Sodium stibogluconate—Chest pain—Methotrexate—testicular cancer	0.000856	0.000856	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—testicular cancer	0.000852	0.000852	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—testicular cancer	0.000844	0.000844	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—testicular cancer	0.000831	0.000831	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—testicular cancer	0.000827	0.000827	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Methotrexate—testicular cancer	0.00082	0.00082	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—testicular cancer	0.00082	0.00082	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—testicular cancer	0.000815	0.000815	CcSEcCtD
Sodium stibogluconate—Infection—Methotrexate—testicular cancer	0.000815	0.000815	CcSEcCtD
Sodium stibogluconate—Nausea—Etoposide—testicular cancer	0.000814	0.000814	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—testicular cancer	0.000801	0.000801	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Methotrexate—testicular cancer	0.000793	0.000793	CcSEcCtD
Sodium stibogluconate—Anorexia—Methotrexate—testicular cancer	0.000782	0.000782	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—testicular cancer	0.000781	0.000781	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—testicular cancer	0.000769	0.000769	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—testicular cancer	0.000768	0.000768	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—testicular cancer	0.000768	0.000768	CcSEcCtD
Sodium stibogluconate—Hypotension—Methotrexate—testicular cancer	0.000767	0.000767	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—testicular cancer	0.000765	0.000765	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—testicular cancer	0.000754	0.000754	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—testicular cancer	0.000742	0.000742	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—testicular cancer	0.000739	0.000739	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Methotrexate—testicular cancer	0.000737	0.000737	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Methotrexate—testicular cancer	0.000731	0.000731	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—testicular cancer	0.000717	0.000717	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Methotrexate—testicular cancer	0.000713	0.000713	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—testicular cancer	0.00071	0.00071	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—testicular cancer	0.00071	0.00071	CcSEcCtD
Sodium stibogluconate—Fatigue—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—testicular cancer	0.000706	0.000706	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000671	0.000671	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—testicular cancer	0.000667	0.000667	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—testicular cancer	0.000657	0.000657	CcSEcCtD
Sodium stibogluconate—Urticaria—Methotrexate—testicular cancer	0.000652	0.000652	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Methotrexate—testicular cancer	0.000649	0.000649	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Methotrexate—testicular cancer	0.000649	0.000649	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—testicular cancer	0.000638	0.000638	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—testicular cancer	0.000633	0.000633	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—testicular cancer	0.000618	0.000618	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—testicular cancer	0.000608	0.000608	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—testicular cancer	0.000607	0.000607	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—testicular cancer	0.000607	0.000607	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Methotrexate—testicular cancer	0.000604	0.000604	CcSEcCtD
Sodium stibogluconate—Asthenia—Methotrexate—testicular cancer	0.000589	0.000589	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Sodium stibogluconate—Pruritus—Methotrexate—testicular cancer	0.00058	0.00058	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—testicular cancer	0.000562	0.000562	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—testicular cancer	0.000562	0.000562	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Methotrexate—testicular cancer	0.000561	0.000561	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—testicular cancer	0.000551	0.000551	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Sodium stibogluconate—Dizziness—Methotrexate—testicular cancer	0.000543	0.000543	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—testicular cancer	0.000523	0.000523	CcSEcCtD
Sodium stibogluconate—Vomiting—Methotrexate—testicular cancer	0.000522	0.000522	CcSEcCtD
Sodium stibogluconate—Rash—Methotrexate—testicular cancer	0.000517	0.000517	CcSEcCtD
Sodium stibogluconate—Dermatitis—Methotrexate—testicular cancer	0.000517	0.000517	CcSEcCtD
Sodium stibogluconate—Headache—Methotrexate—testicular cancer	0.000514	0.000514	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—testicular cancer	0.00051	0.00051	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—testicular cancer	0.000503	0.000503	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Sodium stibogluconate—Nausea—Methotrexate—testicular cancer	0.000487	0.000487	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—testicular cancer	0.000486	0.000486	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—testicular cancer	0.000481	0.000481	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—testicular cancer	0.000456	0.000456	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—testicular cancer	0.000422	0.000422	CcSEcCtD
